Status:

UNKNOWN

Temperature Recording in Lungs of Volunteers With and Without Pulmonary Diseases

Lead Sponsor:

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Conditions:

Temperature Change, Body

Bronchiectasis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of the project is to estimate the air temperature in the lungs after a change from room temperature (25℃) to an environment with a constant temperature of 88-92℃ in resp. lung-healthy pers...

Detailed Description

Heat is a widely available therapeutic modality and is often used for recovery after physical activity and pain treatment, and sauna bathing is a form of whole body thermotherapy ranging from 80-100 ℃...

Eligibility Criteria

Inclusion

  • Lung-healthy group:
  • Inclusion criteria:
  • Age ≥ 18 years
  • Competent and capable
  • Forced expiratory volume in the first second (FEV1)\>1,0 L
  • Does not suffer from bronchiectasis, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, sarcoidosis, active lung infection (past 30 days) or lung cancer
  • Exclusion criteria:
  • Allergy to lidocaine and/or midazolam
  • Contraindications to bronchoscopy\*
  • Previous severe laryngospasm (intubation requiring)
  • Pregnancy/breastfeeding
  • Severe linguistic problems or inability to give informed consent
  • Severe mental illness that is not controlled with medication. NB: Patients with controlled mental illness can be included and will be asked on an equal footing as others
  • Bronchiectasis group:
  • Inclusion criteria:
  • Age ≥ 18 years
  • Competent and capable
  • FEV1\>1,0 L
  • Have diagnosed bronchiectasis \[radiology verified and evaluated by pulmonary specialist\]
  • Exclusion criteria:
  • Allergy to lidocaine and/or midazolam
  • Contraindications to bronchoscopy\*
  • Previous severe laryngospasm (intubation requiring)
  • Pregnancy/breastfeeding
  • Severe linguistic problems or inability to give informed consent
  • Severe mental illness that is not controlled with medication. NB: Patients with controlled mental illness can be included and will be asked on an equal footing as others

Exclusion

    Key Trial Info

    Start Date :

    September 1 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2025

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT05344300

    Start Date

    September 1 2022

    End Date

    September 1 2025

    Last Update

    September 1 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of Medicine, Section of Respiratory Medicine, Herlev and Gentofte Hospital

    Gentofte Municipality, Copenhagen, Denmark, 2900